Answers are grounded in this paper and cite their sources.
Anti-HMGCR myopathy is decribed as an immune-mediated necrotizing myopathy which is characterised by subacute, progressive proximal muscle weakness and elevated creatine kinase (CK) level. In pediatric population, anti-HMGCR myopathy has been reported solely as small case reports, albeit rare. Although treatment consensus has not yet been established, proper treatment with several immunomodulators to include IVIg can show remarkable improvement. We report an 11-year-old-girl diagnosed with anti-HMGCR myopathy with 6 years of follow-up.
No takes yet. Share an insight, caveat, or question.
Çavuşoğlu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: